⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NUVL News
Nuvalent, Inc. Class A Common Stock
Cancer's Toughest Targets Are Drawing Wall Street's Attention as Oncology Innovation Accelerates
globenewswire.com
NTHI
GSK
NUVL
PFE
NUVL Stock Alert: Halper Sadeh LLC is Investigating Whether Nuvalent, Inc. is Obtaining a Fair Price for its Shareholders
businesswire.com
NUVL
Form 8-K
sec.gov
NUVL
How To Strengthen Launch Strategies With Medical-Commercial Collaboration, Upcoming Webinar Hosted by Xtalks
prnewswire.com
KALV
NUVL
AMPL
Nuvalent Announces Key Program and Business Updates, Strengthening Foundation for Global Leadership in ROS1- and ALK-positive NSCLC
prnewswire.com
NUVL
Nuvalent Highlights Upcoming Data Presentations for Neladalkib and Zidesamtinib at the 2026 American Society of Clinical Oncology Annual Meeting
prnewswire.com
NUVL
Form 8-K
sec.gov
NUVL
Nuvalent Highlights Recent Pipeline Progress, Reiterates Key Anticipated Milestones, and Reports First Quarter 2026 Financial Results
prnewswire.com
NUVL
Guardant Health Announces Multi-Year Strategic Collaboration with Nuvalent to Develop Companion Diagnostics and Support Potential Commercialization of Targeted Cancer Therapies Using the Guardant Infinity™ Platform
businesswire.com
GH
NUVL
Nuvalent to Present Pivotal Data from ALKOVE-1 Trial of Neladalkib in TKI Pre-treated Advanced ALK-positive NSCLC at the 2026 American Society of Clinical Oncology Annual Meeting
prnewswire.com
NUVL